146 related articles for article (PubMed ID: 17545796)
1. Treatment of patients with advanced soft tissue sarcoma: disappointment or challenge?
Kasper B; Gil T; Awada A
Curr Opin Oncol; 2007 Jul; 19(4):336-40. PubMed ID: 17545796
[TBL] [Abstract][Full Text] [Related]
2. Novel treatment strategies for soft tissue sarcoma.
Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
[TBL] [Abstract][Full Text] [Related]
3. Standards and novel therapeutic options in the treatment of patients with soft tissue sarcoma.
Kasper B
Rev Recent Clin Trials; 2007 Sep; 2(3):206-11. PubMed ID: 18474006
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
5. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
6. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
7. The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
Tascilar M; Loos WJ; Seynaeve C; Verweij J; Sleijfer S
Oncologist; 2007 Nov; 12(11):1351-60. PubMed ID: 18055856
[TBL] [Abstract][Full Text] [Related]
8. New targets for therapy of sarcoma.
Magenau JM; Schuetze SM
Curr Opin Oncol; 2008 Jul; 20(4):400-6. PubMed ID: 18525335
[TBL] [Abstract][Full Text] [Related]
9. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
[TBL] [Abstract][Full Text] [Related]
11. New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma.
Schmitt T; Kasper B
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1159-67. PubMed ID: 19671035
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in adult soft tissue sarcoma.
Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
Todd R; Lunec J
Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
[TBL] [Abstract][Full Text] [Related]
14. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.
Mocellin S; Rossi CR; Brandes A; Nitti D
Cancer Treat Rev; 2006 Feb; 32(1):9-27. PubMed ID: 16338075
[TBL] [Abstract][Full Text] [Related]
15. New emerging drugs in soft tissue sarcoma.
Milano A; Apice G; Ferrari E; Fazioli F; de Rosa V; de Luna AS; Iaffaioli RV; Caponigro F
Crit Rev Oncol Hematol; 2006 Jul; 59(1):74-84. PubMed ID: 16533604
[TBL] [Abstract][Full Text] [Related]
16. Role of chemotherapy in patients with soft tissue sarcomas.
Maki RG
Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy in soft tissue sarcomas].
Zelek L
Cancer Radiother; 2006; 10(1-2):68-71. PubMed ID: 16380283
[TBL] [Abstract][Full Text] [Related]
18. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.
Verweij J; Baker LH
Eur J Cancer; 2010 Mar; 46(5):863-8. PubMed ID: 20138507
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies for soft-tissue sarcomas.
Tap WD; Federman N; Eilber FC
Expert Rev Anticancer Ther; 2007 May; 7(5):725-33. PubMed ID: 17492935
[TBL] [Abstract][Full Text] [Related]
20. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]